LINC00538: A Drug Target / Disease Biomarker (G100861504)

Target Name: LINC00538

NCBI ID: G100861504

LINC00538

Other Name(s): Yiya | long intergenic non-protein coding RNA 538 | PROX1UT | Long intergenic non-protein coding RNA 538

LINC00538: A Drug Target / Disease Biomarker

LINC00538 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is long non-coding RNA gene 538. LINC00538 is a potential drug target and has been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The LINC00538 gene is located on chromosome 6p21.2 and encodes a protein that is composed of 254 amino acid residues. The protein has several unique features that make it an interesting potential drug target. One of the most notable is its ability to form a monomeric form in the brain, which is unusual for a protein that is not known to have a natural monomeric form. Additionally, the protein has a predicted localization in the brain, which suggests that it may be involved in the development and progression of neurodegenerative diseases.

In addition to its unique physical features, LINC00538 has also been shown to play a role in several diseases. For example, studies have shown that LINC00538 is overexpressed in various tissues of the brain, including the brain and spinal cord, in individuals with neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, the protein has also been shown to be overexpressed in various types of cancer, which suggests that it may be a potential biomarker for cancer.

Another potential application of LINC00538 as a drug target is its ability to interact with several different signaling pathways. For example, studies have shown that LINC00538 can interact with the PDGF signaling pathway, which is involved in the development and maintenance of tissues in the brain. Additionally, the protein has also been shown to interact with the TGF-β signaling pathway, which is involved in the development and regulation of tissues in the body.

Overall, LINC00538 is a protein that has several unique physical features that make it an interesting potential drug target. Its ability to form a monomeric form in the brain and its predicted localization in the brain suggest that it may be involved in the development and progression of neurodegenerative diseases. Additionally, the protein has also been shown to interact with several different signaling pathways, which suggests that it may be a potential biomarker for a variety of diseases. Further research is needed to determine the full role of LINC00538 in the body and its potential as a drug target.

Protein Name: Long Intergenic Non-protein Coding RNA 538

The "LINC00538 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00538 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets